• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Who should code cause of death in a clinical trial?

作者信息

Remington R D

出版信息

Control Clin Trials. 1984 Sep;5(3):241-4. doi: 10.1016/0197-2456(84)90027-8.

DOI:10.1016/0197-2456(84)90027-8
PMID:6488808
Abstract

Clinical trials of intervention in chronic disease often use cause-specific mortality as a principal outcome variable. Surprisingly, there has been little standardization of the approach to determining cause of death. Some studies use standard nosological coding based on the International Statistical Classification of Diseases while others rely on panels of physicians. Some studies utilize autopsy findings; others do not. There is a clear need for standardization, and a unified approach is suggested. In this approach, panels of physicians prepare death certificates and are trained and standardized to generate reproducible information. A system for adjudication of differences is a part of the trial's design. Death certificates are then transmitted to panels of nosologists who assign cause of death. Again, the nosologists are standardized, and an adjudication system for resolving differences is developed. This two-stage system takes advantage of strengths of the two types of cause of death coding now in use in clinical trials and should produce results permitting cross-trial and cross-time comparisons.

摘要

相似文献

1
Who should code cause of death in a clinical trial?
Control Clin Trials. 1984 Sep;5(3):241-4. doi: 10.1016/0197-2456(84)90027-8.
2
Standardized physician preparation of death certificates.医生开具死亡证明的标准化流程。
Control Clin Trials. 1987 Jun;8(2):110-20. doi: 10.1016/0197-2456(87)90036-5.
3
Nosological coding of cause of death.死亡原因的疾病分类编码。
Am J Epidemiol. 1983 Jul;118(1):122-8. doi: 10.1093/oxfordjournals.aje.a113613.
4
Value of an Endpoints Committee versus the use of nosologists for validating cause of death.终点判定委员会相对于使用疾病分类学家来验证死亡原因的价值。
Contemp Clin Trials. 2006 Aug;27(4):333-9. doi: 10.1016/j.cct.2005.11.007. Epub 2006 Jan 4.
5
Epidemiological transition in a rural community of northern India: 18-year mortality surveillance using verbal autopsy.印度北部农村社区的流行病学转变:使用死因推断法进行 18 年的死亡率监测。
J Epidemiol Community Health. 2012 Oct;66(10):890-3. doi: 10.1136/jech-2011-200336. Epub 2011 Nov 2.
6
The international comparability of cancer mortality data. Results of an international death certificate study.癌症死亡率数据的国际可比性。一项国际死亡证明研究的结果。
Am J Epidemiol. 1989 May;129(5):934-46. doi: 10.1093/oxfordjournals.aje.a115226.
7
Reporting of incorrect cause-of-death causal sequence on death certificates in the USA: using hypertension and diabetes as an educational illustration.美国死亡证明中错误死因因果序列报告:以高血压和糖尿病为例进行教育说明。
Postgrad Med J. 2012 Dec;88(1046):690-3. doi: 10.1136/postgradmedj-2012-130912. Epub 2012 Sep 18.
8
The necessary role of the autopsy in cardiovascular epidemiology.尸检在心血管流行病学中的必要作用。
Hum Pathol. 1998 Dec;29(12):1469-79. doi: 10.1016/s0046-8177(98)90018-1.
9
[Coding of cause of death for mortality statistics--a comparison with results of coding by various statistical offices of West Germany and West Berlin].[死亡率统计中死因编码——与西德和西柏林各统计局编码结果的比较]
Offentl Gesundheitswes. 1989 Jan;51(1):40-7.
10
Using the National Death Index to obtain underlying cause of death codes.使用国家死亡索引获取根本死因编码。
J Occup Environ Med. 1998 Sep;40(9):808-13. doi: 10.1097/00043764-199809000-00010.

引用本文的文献

1
Estimating breast cancer-specific and other-cause mortality in clinical trial and population-based cancer registry cohorts.在临床试验和基于人群的癌症登记队列中估计乳腺癌特异性死亡率和其他原因死亡率。
Cancer. 2009 Nov 15;115(22):5272-83. doi: 10.1002/cncr.24617.
2
Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.肥胖、他莫昔芬的使用与雌激素受体阳性早期乳腺癌女性的预后
J Natl Cancer Inst. 2003 Oct 1;95(19):1467-76. doi: 10.1093/jnci/djg060.
3
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study.
国际临床试验中中央临床事件委员会与现场研究者对心肌梗死终点评估的分歧:PURSUIT研究综述
Curr Control Trials Cardiovasc Med. 2001 Jul 17;2(4):187-194. doi: 10.1186/cvm-2-4-187.
4
Systematic adjudication of myocardial infarction end-points in an international clinical trial.一项国际临床试验中心肌梗死终点的系统判定
Curr Control Trials Cardiovasc Med. 2001 Jul 17;2(4):180-186. doi: 10.1186/cvm-2-4-180.